CONTROLLED RELEASE OF THEOPHYLLINE FROM CROSS-LINKED AMYLOSE TABLETS

被引：91

作者：

LENAERTS, V

DUMOULIN, Y

MATEESCU, MA

机构：

[1] Faculté de Pharmacie, Université de Montréal, Montréal, Que. H3C 3J7

来源：

JOURNAL OF CONTROLLED RELEASE | 1991年 / 15卷 / 01期

基金：

加拿大自然科学与工程研究理事会;

关键词：

CONTROLLED RELEASE OF THEOPHYLLINE; CROSS-LINKED AMYLOSE; POLYHYDROXYLIC POLYMERS; BIOCOMPATIBLE POLYMERS;

D O I：

10.1016/0168-3659(91)90101-I

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Amylose cross-linked (CLA) by epichlorohydrin treatment is introduced as a matrix for controlled release of drugs. Different reticulation degrees were obtained by varying the ratio of epichlorohydrin to amylose. A linear release of theophylline from the CLA tablets was observed in all cases. Linear increase of the cross-linking degree of the CLA used for tablet preparation generated non-linear diminution of the release time. For tablets obtained from CLA-7.5 (the lowest reticulation degree, realized by cross-linking of 100 g of amylose with 7.5 g of epichlorohydrin) containing theophylline up to 20% (w/w), a close to linear release was found over a period up to 15 h. For moderate increase of the cross-linking degree (CLA-12 and CLA-20) the release time was drastically decreased to 1-2 h. Release retardation in CLA-7.5 tablets seems to be related to the high amylose hydrogen interchain associations. Equilibrium swelling experiments in water and in 8 M urea support this hypothesis. The duration of the near-linear slow release was related to the duration of tablet swelling. The analysis of the data indicates that an anomalous release mechanism controls the transport of the drug; this includes neither Fickian diffusion nor glassy/rubbery transition. A hypothesis of a type of release controlled by hydrogen association is advanced.

引用

页码：39 / 46

页数：8

共 13 条

[1]

Buri, Doelker, Formulation de comprimés à libération prolongée. II. Matrices hydrophiles, Pharm. Acta Helv., 55, pp. 189-197, (1980)

[2]

Peppas, Bindschaedler, Les dispositifs à libération contrôlée pour la délivrance des principes actifs médicamenteux. IV. Systèmes à gonflement contrôlé, STP Pharma., 2, pp. 38-46, (1986)

[3]

Peppas, Franson, The swelling interface number as a criterion for prediction of diffusional solute release mechanism in swellable polymers, J. Polym. Sci., 21, pp. 983-997, (1983)

[4]

Lee, Novel approach to zero-order drug delivery via immobilized non-uniform drug distribution in glassy hydrogels, J. Pharm. Sci., 73, pp. 1344-1347, (1984)

[5]

Embrey, Graham, McNeill, Millier, In vitro release characteristics and long term stability of poly (ethylene oxide) hydrogel vaginal pessaries containing prostaglandin E<sub>2</sub>, J. Controlled Release, 3, pp. 39-45, (1986)

[6]

Jusko, Gardner, Mangione, Schentag, Koup, Vance, Factors affecting theophylline clearances: age, tobacco, marijuana, oral contraceptives, benzodiazepines, barbiturates and ethanol, J. Pharm. Sci., 68, pp. 1358-1366, (1979)

[7]

Mateescu, Schell, A new amyloclastic method for the selective determination of alpha-amylase using cross-linked amylose as insoluble substrate, Carbohydr. Res., 124, pp. 319-323, (1983)

[8]

Ostafe, Szedlacsek, Mateescu, Aspects concerning the preparation of cross-linked starch and its behavior as a substrate for alpha-amylase, Stud. Cercet. Biochim., 27, pp. 149-157, (1984)

[9]

Serban, Schell, Mateescu, Amylose derivatives for use in gel-filtration, (1976)

[10]

Ghetie, Schell, Drying of agarose gel beads, Experientia, 27, pp. 1384-1385, (1971)

← 1 2 →